Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ · Healthcare
Arcutis Biotherapeutics Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Arcutis Biotherapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 243.5M, a 27.25% increase year-over-year.
- Arcutis Biotherapeutics Inc. total liabilities for 2025 were 243.5M, a 27.25% increase from 2024.
- Arcutis Biotherapeutics Inc. total liabilities for 2024 were 191.3M, a 24.28% decrease from 2023.
- Arcutis Biotherapeutics Inc. total liabilities for 2023 were 252.7M, a 5.43% increase from 2022.
- Arcutis Biotherapeutics Inc. total liabilities for 2022 were 239.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Arcutis Biotherapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $243 |
| 2024 | $191 |
| 2023 | $253 |
| 2022 | $240 |
| 2021 | $110 |
| 2020 | $28 |
| Arcutis Biotherapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $243 |
| 2024-12-31 | $191 |
| 2023-12-31 | $253 |
| 2022-12-31 | $240 |
| 2021-12-31 | $110 |
| 2020-12-31 | $28 |
Arcutis Biotherapeutics Inc. Total Liabilities — FAQ
Arcutis Biotherapeutics Inc. (ARQT) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARQT's total liabilities history?
The chart and table above show Arcutis Biotherapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.